BORELLA, MIRIAM
 Distribuzione geografica
Continente #
NA - Nord America 159
EU - Europa 143
AS - Asia 51
SA - Sud America 1
Totale 354
Nazione #
US - Stati Uniti d'America 159
RU - Federazione Russa 65
IT - Italia 35
CN - Cina 20
HK - Hong Kong 14
SE - Svezia 12
IE - Irlanda 11
SG - Singapore 10
CH - Svizzera 6
FI - Finlandia 5
JO - Giordania 5
DE - Germania 4
IN - India 2
UA - Ucraina 2
BR - Brasile 1
FR - Francia 1
GB - Regno Unito 1
NL - Olanda 1
Totale 354
Città #
Santa Clara 73
Dublin 11
Hong Kong 11
Fairfield 10
Singapore 9
Ashburn 8
Chandler 8
Florence 8
Bern 6
Houston 6
Helsinki 5
Woodbridge 5
Altamura 4
Lawrence 4
Napoli 4
Beijing 3
Cambridge 3
Wilmington 3
Buffalo 2
Chengdu 2
Falkenstein 2
Montepiano 2
Moscow 2
Mumbai 2
Princeton 2
San Giovanni Valdarno 2
Sant'elpidio A Mare 2
Shanghai 2
Washington 2
Abenberg 1
Ann Arbor 1
Baoding 1
Boardman 1
Boston 1
Bremen 1
Catanzaro 1
Hangzhou 1
Jacksonville 1
Kent 1
Leawood 1
Medford 1
Monteriggioni 1
Seattle 1
Southwark 1
Specchia 1
São Paulo 1
Xingtai 1
Totale 221
Nome #
Compassionate use of JAK1/2 inhibitor ruxolitinib for severe COVID-19: a prospective observational study 131
Integration of multiparameter flow cytometry score improves prognostic stratification provided by standard models in primary myelofibrosis 87
Impaired response to first SARS-CoV-2 dose vaccination in myeloproliferative neoplasm patients receiving ruxolitinib 80
Humoral and cellular responses after third dose of SARS-CoV-2 vaccine in myeloproliferative neoplasms patients on ruxolitinib therapy 65
Validation and molecular integration of the RR6 model to predict survival after 6 months of therapy with ruxolitinib 2
Totale 365
Categoria #
all - tutte 1.626
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 1.626


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/202138 0 0 21 8 2 0 0 4 0 1 2 0
2021/202230 0 9 0 1 3 2 0 0 2 0 7 6
2022/202363 4 12 3 5 1 11 7 1 8 3 2 6
2023/202456 3 7 6 4 2 3 1 15 2 4 5 4
2024/2025178 7 21 15 40 61 34 0 0 0 0 0 0
Totale 365